Inventor · disambiguated record
Luca Raveglia
Also filed as: RAVEGLIA LUCA · RAVEGLIA LUCA F · RAVEGLIA LUCA FRANCESCO · RAVEGLIA LUCA FRANCESCO MARIO
25 granted patents·17 pending applications·241 citations·filing 1995–2021
96Inventor score
Top patents by PatentIndex Score
42 records- 0190US5811553AQuinoline derivatives(2)SMITHKLINE BEECHAM FARMA·Filed 1995·Granted Sep 22, 1998·68 cites·2 claims
- 0288US8969347B2Compounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2012·Granted Mar 3, 2015·10 cites·22 claims
- 0387US8022250B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2009·Granted Sep 20, 2011·10 cites·6 claims
- 0487US7482458B2Quinoline derivativesSMITHKLINE BEECHAM FARMA·Filed 2006·Granted Jan 27, 2009·8 cites·1 claims
- 0583US9290450B2Compounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2014·Granted Mar 22, 2016·5 cites·27 claims
- 0682US8304413B2Compounds and methods for treating inflammatory and fibrotic disordersKOSSEN KARL·Filed 2009·Granted Nov 6, 2012·8 cites·19 claims
- 0781US6743804B2Quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 2002·Granted Jun 1, 2004·11 cites·1 claims
- 0879US7662995B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2004·Granted Feb 16, 2010·12 cites·26 claims
- 0978US6277862B1Quinoline derivativesSMITHKLINE BEECHAM SPA·Filed 1996·Granted Aug 21, 2001·47 cites·29 claims
- 1074US9580416B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Feb 28, 2017·2 cites·18 claims
- 1174US6432977B1Salts of quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 2001·Granted Aug 13, 2002·8 cites·3 claims
- 1272US8314268B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesRAVEGLIA LUCA·Filed 2011·Granted Nov 20, 2012·3 cites·18 claims
- 1372US6780875B2Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonistsSMITHKLINE BEECHAM SPA·Filed 2003·Granted Aug 24, 2004·6 cites·6 claims
- 1470US6608083B1Quinoline derivatives(2)SMITHKLINE BEECHAM FARMA·Filed 1995·Granted Aug 19, 2003·21 cites·54 claims
- 1569US7531692B2Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2005·Granted May 12, 2009·1 cites·21 claims
- 1669US6696457B1Morphinoid compoundsSMITHKLINE BEECHAM PLC·Filed 2000·Granted Feb 24, 2004·5 cites·5 claims
- 1763US2007197546A1Quinoline-4-carboxamide as nk-2 and nk-3 receptor antagonistsSMITHKLINE BEECHAM SPA ITALY·Filed 2007·Application pending·0 cites
- 1861USRE47142ECompounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2014·Granted Nov 27, 2018·0 cites·19 claims
- 1960US2006205735A1Quinoline-4-carboxamide as NK-2 and NK-3 receptor antagonistsMARIA GLARDINA GIUSEPPE A·Filed 2006·Application pending·0 cites
- 2060US2005096316A1Quinoline derivatives(2)Filed 2004·Application pending·0 cites
- 2159US6355654B1Salts of quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 1996·Granted Mar 12, 2002·11 cites·6 claims
- 2258US2021070748A1Inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 2357US2005159428A1Quinoline-4-carboxamide derivatives asNK-2 and NK-3 receptor antagonistsSMITHKLINE BEECHAM SPA ITALY·Filed 2005·Application pending·0 cites
- 2455US8063039B23-aminopyrrolidone derivativesTHALER FLORIAN·Filed 2009·Granted Nov 22, 2011·0 cites·10 claims
- 2554US12454530B2Amido cyclohexane acid derivatives as LPA receptor inhibitorsCHIESI FARM SPA·Filed 2021·Granted Oct 28, 2025·0 cites·11 claims
- 2653US2004116469A1Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonistsSMITHKLINE BEECHAM SPA·Filed 2003·Application pending·0 cites
- 2751US2003236281A1Quinoline derivatives(2)Filed 2001·Application pending·0 cites
- 2850US7968592B23-aminopyrrolidone derivativesNEWRON PHARM SPA·Filed 2004·Granted Jun 28, 2011·0 cites·2 claims
- 2950US2002156097A1Salts of quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 2002·Application pending·0 cites
- 3049US2023043672A1Aromatic amido derivatives as lpa receptor 2 inhibitorsCHIESI FARM SPA·Filed 2020·Application pending·0 cites
- 3149US2023061417A1Thienopyrimidine derivatives as lpa receptor 2 inhibitorsCHIESI FARM SPA·Filed 2020·Application pending·0 cites
- 3249US2003004183A1Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonistsFiled 2002·Application pending·0 cites
- 3348US12404270B2Quinazoline derivatives as LPA receptor 2 inhibitorsCHIESI FARM SPA·Filed 2020·Granted Sep 2, 2025·0 cites·16 claims
- 3447US2024190860A18-cyclo-substituted quinazoline derivatives as lpa receptor 2 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 3547US2001012846A1Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonistsFiled 2000·Application pending·0 cites
- 3645US2010249123A1Novel benzamide derivatives as modulators of the follicle stimulating hormoneADDEX PHARMA SA·Filed 2008·Application pending·0 cites
- 3744US6613770B1Quinoline derivatives as NK-2 and NK-3 receptor ligandsSMITHKLINE BEECHAM SPA·Filed 1999·Granted Sep 2, 2003·5 cites·10 claims
- 3843US8835494B2Derivatives of 1-(2-halo-biphenyl-4-yl)-Alkanecarboxylic for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2013·Granted Sep 16, 2014·0 cites·19 claims
- 3943US2018305348A1Inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 4040US11660293B2Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonistsCHRONOS THERAPEUTICS LTD·Filed 2018·Granted May 30, 2023·0 cites·20 claims
- 4140US2009005364A1Azole Derivatives With Antimuscarinic ActivityPERETTO ILARIA·Filed 2005·Application pending·0 cites
- 4240US2002068827A1Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonistsSMITHKLINE BEECHAM SPA·Filed 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →